Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Non-cash Items (2016 - 2025)

Aethlon Medical filings provide 13 years of Non-cash Items readings, the most recent being $1512.0 for Q1 2025.

  • On a quarterly basis, Non-cash Items fell 79.1% to $1512.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $1512.0, a 79.1% decrease, with the full-year FY2025 number at $1512.0, down 79.1% from a year prior.
  • Non-cash Items hit $1512.0 in Q1 2025 for Aethlon Medical, down from $7236.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $1.7 million in Q2 2021 to a low of $1512.0 in Q1 2025.
  • Median Non-cash Items over the past 5 years was $267221.0 (2022), compared with a mean of $392401.2.
  • Biggest five-year swings in Non-cash Items: surged 2170.61% in 2021 and later crashed 90.42% in 2024.
  • Aethlon Medical's Non-cash Items stood at $166717.0 in 2021, then skyrocketed by 201.1% to $501985.0 in 2022, then plummeted by 82.83% to $86180.0 in 2023, then plummeted by 91.6% to $7236.0 in 2024, then tumbled by 79.1% to $1512.0 in 2025.
  • The last three reported values for Non-cash Items were $1512.0 (Q1 2025), $7236.0 (Q1 2024), and $86180.0 (Q3 2023) per Business Quant data.